Language:
English
繁體中文
Help
圖資館首頁
Login
Back
Switch To:
Labeled
|
MARC Mode
|
ISBD
Antibody therapysubstitution - immun...
~
Imbach, Paul.
Antibody therapysubstitution - immunomodulation - monoclonal immunotherapy /
Record Type:
Electronic resources : Monograph/item
Title/Author:
Antibody therapyedited by Paul Imbach.
Reminder of title:
substitution - immunomodulation - monoclonal immunotherapy /
other author:
Imbach, Paul.
Published:
Cham :Springer International Publishing :2018.
Description:
xiv, 363 p. :ill., digital ;24 cm.
Contained By:
Springer eBooks
Subject:
ImmunoglobulinsTherapeutic use.
Online resource:
http://dx.doi.org/10.1007/978-3-319-68038-5
ISBN:
9783319680385$q(electronic bk.)
Antibody therapysubstitution - immunomodulation - monoclonal immunotherapy /
Antibody therapy
substitution - immunomodulation - monoclonal immunotherapy /[electronic resource] :edited by Paul Imbach. - Cham :Springer International Publishing :2018. - xiv, 363 p. :ill., digital ;24 cm.
This practical manual, written by well-known experts, reviews current indications for the use of IgG concentrates and some other modern immunomodulators and provides fundamental information on present-day immunomodulation in patients (and mice) The book opens by tracing the transition from IgG substitution to IgG immunomodulation and providing expert updates on immunomodulatory indications in autoimmune and inflammatory disorders, including hematologic, neurologic, dermatologic, and other diseases. Basic aspects of IgG concentrates, including methods of production, safety, currently available products, and mechanisms of action, are then discussed. An entire chapter is devoted to the different aspects of immunomodulatory IgG treatment in the bleeding disorder immune thrombocytopenia (ITP) Finally, the transition from polyclonal to monoclonal antibody (mAb) treatment is addressed in detail, covering mAb development, methods, mechanisms of action, adverse effects, and more. Particular attention is paid to the example of anti-CD20 (B-cell) antibody.
ISBN: 9783319680385$q(electronic bk.)
Standard No.: 10.1007/978-3-319-68038-5doiSubjects--Topical Terms:
274315
Immunoglobulins
--Therapeutic use.
LC Class. No.: QR186.7 / .A585 2018
Dewey Class. No.: 616.0792
Antibody therapysubstitution - immunomodulation - monoclonal immunotherapy /
LDR
:02003nmm a2200301 a 4500
001
534023
003
DE-He213
005
20181015141251.0
006
m d
007
cr nn 008maaau
008
181205s2018 gw s 0 eng d
020
$a
9783319680385$q(electronic bk.)
020
$a
9783319680378$q(paper)
024
7
$a
10.1007/978-3-319-68038-5
$2
doi
035
$a
978-3-319-68038-5
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
QR186.7
$b
.A585 2018
072
7
$a
MJF
$2
bicssc
072
7
$a
MED038000
$2
bisacsh
082
0 4
$a
616.0792
$2
23
090
$a
QR186.7
$b
.A629 2018
245
0 0
$a
Antibody therapy
$h
[electronic resource] :
$b
substitution - immunomodulation - monoclonal immunotherapy /
$c
edited by Paul Imbach.
260
$a
Cham :
$b
Springer International Publishing :
$b
Imprint: Springer,
$c
2018.
300
$a
xiv, 363 p. :
$b
ill., digital ;
$c
24 cm.
520
$a
This practical manual, written by well-known experts, reviews current indications for the use of IgG concentrates and some other modern immunomodulators and provides fundamental information on present-day immunomodulation in patients (and mice) The book opens by tracing the transition from IgG substitution to IgG immunomodulation and providing expert updates on immunomodulatory indications in autoimmune and inflammatory disorders, including hematologic, neurologic, dermatologic, and other diseases. Basic aspects of IgG concentrates, including methods of production, safety, currently available products, and mechanisms of action, are then discussed. An entire chapter is devoted to the different aspects of immunomodulatory IgG treatment in the bleeding disorder immune thrombocytopenia (ITP) Finally, the transition from polyclonal to monoclonal antibody (mAb) treatment is addressed in detail, covering mAb development, methods, mechanisms of action, adverse effects, and more. Particular attention is paid to the example of anti-CD20 (B-cell) antibody.
650
0
$a
Immunoglobulins
$x
Therapeutic use.
$3
274315
650
1 4
$a
Medicine & Public Health.
$3
273799
650
2 4
$a
Hematology.
$3
274899
650
2 4
$a
Immunology.
$3
189152
650
2 4
$a
Oncology.
$3
195181
700
1
$a
Imbach, Paul.
$3
261813
710
2
$a
SpringerLink (Online service)
$3
273601
773
0
$t
Springer eBooks
856
4 0
$u
http://dx.doi.org/10.1007/978-3-319-68038-5
950
$a
Medicine (Springer-11650)
based on 0 review(s)
ALL
電子館藏
Items
1 records • Pages 1 •
1
Inventory Number
Location Name
Item Class
Material type
Call number
Usage Class
Loan Status
No. of reservations
Opac note
Attachments
000000154612
電子館藏
1圖書
電子書
EB QR186.7 .A629 2018 2018
一般使用(Normal)
On shelf
0
1 records • Pages 1 •
1
Multimedia
Multimedia file
http://dx.doi.org/10.1007/978-3-319-68038-5
Reviews
Add a review
and share your thoughts with other readers
Export
pickup library
Processing
...
Change password
Login